Lisa is the strategic lead for promoting and building patient centered products, and solutions that fit into people’s lives and improve healthcare outcomes. This includes leveraging current programs such as patient support programs, as well as creation and development of new mechanisms for improving patient outcomes though both internal and external collaborations. Lisa’s role is to build a global platform for patient centered capabilities to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers.

Lisa comes to Sanofi as a pharmaceutical executive with expertise in outcomes research and public health. Most recently, she has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to meet the needs of patients, providers, payers and policy makers. In Lisa’s previous roles at Pfizer as Vice President of Medical Affairs and Vice President of Global Outcomes Research, she developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product lifecycle as well as customer-based assessment of both products and services. Additionally, she has created innovative patient focused, multi-sector partnerships to promote health care access, quality and outcomes in numerous populations, ranging from maternal and infant health to the elderly.

Lisa has a B.S. in Biology from the Massachusetts Institute of Technology (M.I.T.) and an M.B.A. in health care management from Wharton School of the University of Pennsylvania; she earned an M.D. and M.P.H. degrees from Johns Hopkins and is board certified in pediatrics.

An internationally renowned thoracic surgeon, researcher, author and academician, Larry R. Kaiser, MD, is the leading health sciences executive at Temple University in Philadelphia, PA. He serves as CEO of the Temple University Health System, Senior Executive Vice President for the Health Sciences, and Dean of Temple University School of Medicine. Prior to joining Temple University Dr. Kaiser was the President of UTHealth, the University of Texas Health Science Center at Houston from 2008 until April 1, 2011.

Dr. Kaiser graduated from Tulane University School of Medicine in 1977 and completed his internship and residency in General Surgery as well as a fellowship in Surgical Oncology at the University of California (Los Angeles). He then completed a residency in cardiovascular surgery and thoracic surgery at the University of Toronto. Following that, he served as a thoracic surgeon at Memorial Sloan-Kettering Cancer Center and Assistant Professor of Surgery at Cornell University Medical College (New York) and was then recruited to Washington University School of Medicine (St. Louis) where he was promoted to Associate Professor of Surgery in 1990.

In 1991, Dr. Kaiser was recruited to the University of Pennsylvania (Philadelphia) where he held a succession of positions of increasing responsibility, including Associate Professor of Surgery, Chief of General Thoracic Surgery, Founder and Director of the university’s lung transplantation program, and Director of its Center for Lung Cancers and Related Disorders. In 1995, he was promoted to Professor of Surgery and in 1996 was named the Eldridge Eliason Professor of Surgery, the first individual to hold that chair. In 2001, following a national search, he was named the John Rhea Barton Professor and Chairman of the Department of the Department of Surgery at Penn.

In 2008, Dr. Kaiser was selected as the President of the University of Texas Health Science Center at Houston. There, he was responsible for six schools, more than 10,000 faculty and trainees, and a 900-member physician practice.

Dr. Kaiser’s research and clinical interests include lung cancer, malignant mesothelioma and mediastinal tumors. He is the author or co-author of 14 books and over 250 original papers.

Dr. Kaiser has served in a number of leadership capacities for professional societies and associations, and has been a director of the American Board of Surgery and the American Board of Thoracic Surgery. In 2004, he was elected to the Institute of Medicine of the National Academy of Sciences. His recent honors include citations in Castle Connolly’s “America’s Top Doctors for Cancer” 6th edition, Who’s Who in the World, and Philadelphia Magazine’s “Top Docs,” among others.

Subha has spent the past twenty nine years in technology leadership roles at Fortune 500 companies in Chemical, Pharma, Media, Retail, Technology, and HealthCare sectors and has also founded a technology startup. He is a passionate technologist, futurist, and digital health evangelist who applies technology to solve problems. Currently at Cigna, Subha is a Senior Director of Innovation R&D;, a team focused on research of emerging and disruptive technologies. His expertise includes applying Cloud, Digital Health, Artificial Intelligence, Machine Learning, Internet of Things, Wearable’s and other disruptive technologies like Blockchain to solve customer centric innovation efforts at Cigna. His current agile R&D; team is part of US Market, Corporate Function and Customer Service organization in Cigna's CIO office. He spearheads projects with many IT/Business leaders in Cigna's global business units to champion new ideas. His team engages from conception through customer journey, ideation, proof of concept/technology pilots and commercial adaptation.

Subha is very active in professional organizations and peer groups in emerging technology. He is a member of the governing board of Hartford InsurTech hub; a startup accelerator created by a joint effort with other industry leaders to innovate in many insurance technology areas. He often speaks in health and insurance technology conferences about digital health, health engagement, and using technology to get better health outcomes. Subha has an MBA from Cornell University, a MS in Industrial Systems Engineering from LSU, and a B.Tech in Chemical Engineering from Anna University, India. He was recognized with American Red Cross (ARC) president’s award for his leadership to restore communication during Katrina relief efforts. He lives with his wife and two children in Nyack, New York and practices digital health, enjoys disruptive technology, travel, and cooking fusion food.

Michelle is the Head of Innovation in Portfolio and Operations for Pharma Development at Bayer. She has over 20 years of experience in Clinical Research across many different roles. She began her journey as a research nurse and site director. From there she became a Clinical Research Associate at a CRO, and finally joined Bayer in 2008 where she has held multiple roles in Clinical Operations, Training and Quality, and now in Business Excellence and Innovation. Michelle’s greatest passion is customer focused innovation and responding to the voice of the patients and sites.

Douglas Stover joined UCB in 2016 to lead the Patient Experience and Value Mission for the Global Neurology Patient Value Unit.

Prior to joining UCB, Douglas spent 10 years with Gallup, a research based consultancy, where he served as a strategic advisor to clients building customer focused cultures. During his time a Gallup, he was also responsible for the overall success of the joint venture between Gallup and Healthways, Inc., whose mission was to redefine how individuals, organizations, communities and countries measure and manage well-being. Previous experience includes senior positions at The Advisory Board, OgilvyOne and ICG Commerce.

Douglas received his Bachelors of Science from the Pennsylvania State University and Masters of Business Administration from Georgetown University.

Chief Medical Officer Allison Suttle, MD, MBA, FACOG, is part of the executive team that defines the overall business strategy and direction for Sanford Health. In addition, she leads the overall clinical vision for the organization with a specific focus on standardization, quality and safety for Sanford Health’s clinical leaders and physicians. As chair and member of Sanford’s Quality Cabinet, Dr. Suttle leads the effort to improve quality by solving difficult issues that enable Sanford Health to achieve excellence in all areas of the Triple Aim, which include improving population health, improving the patient experience and reducing costs. She also plays a significant role in bringing evidenced-based medicine to the electronic medical record (EMR) and other innovative technologies that improve value-based care.

Sanford Health is an integrated health system headquartered in the Dakotas. It is one of the largest health systems in the nation with 45 hospitals and nearly 300 clinics in nine states and four countries. Sanford Health’s 28,000 employees, including over 1,300 physicians, make it the largest employer in the Dakotas. Nearly $1 billion in gifts from philanthropist T. Denny Sanford have allowed for several initiatives, including global children's clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases.

Dr. Suttle has a bachelor’s degree in biochemistry from Brown University where she graduated with honors. She received her MBA from the University of Sioux Falls in South Dakota and completed her medical training at Northwestern University in Chicago and her OB/GYN residency at Advocate Lutheran General Hospital in Park Ridge, Illinois. Following her residency, she moved back to the Sioux Falls area and started practicing at what is now Sanford USD Medical Center where her father was a physician in the radiology department. In 2011, she was named chief medical information officer and has been serving as Sanford Health’s chief medical officer since 2014.

Dr. Suttle has been a Fellow, American College of Obstetricians and Gynecologists since 2003 and is a member of both the South Dakota State Medical Association and Seventh District Medical Society. She also serves on the board of the South Dakota Symphony Orchestra. Originally from South Dakota, she and her husband, Gary, have one son.

Joel Wright was named President and Chief Executive Officer of a combined specialty and mail services company with AllianceRx Walgreens Prime that launched on April of 2017. This combined company is a subsidiary of Walgreens, the Retail Pharmacy USA Division of Walgreens Boots Alliance, and will be headquartered in Chicago, Ill.

Mr. Wright previously was Divisional Vice President of Walgreens Specialty Solutions Group, a division dedicated to providing patients with complete specialized pharmaceutical care to treat chronic, rare or complex conditions. During his tenure from 2013 - 2016, Mr. Wright developed and executed a successful go-to-market strategy for five central specialty and 250 local specialty pharmacies throughout the U.S. and Puerto Rico. Under his leadership, the Specialty Solutions Group nearly doubled its sales and amassed more than $8 million in annual revenue.

Before leading the specialty division, Mr. Wright held a variety of leadership roles of increasing responsibility at Walgreens. He began his Walgreens career 22 years ago as a Pharmacy Manager and Supervisor and has since served as Vice President of Home Care, Executive Director of Pharmacy and Senior Director of Healthy System Operations.

Mr. Wright holds a Bachelor of Pharmacy degree from the Ferris State University in Grand Rapids, MI. He also completed the Executive Management Program for Pharmacy Leaders at University of Pennsylvania’s Wharton School of Business.